{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:53:52Z","timestamp":1759366432658,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.revmed.2023.09.003","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T13:41:02Z","timestamp":1696945262000},"page":"641-645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Myx\u0153d\u00e8me pr\u00e9tibial pseudo-tumoral apr\u00e8s une maladie de Basedow\u00a0: un diagnostic diff\u00e9rentiel du lymph\u0153d\u00e8me"],"prefix":"10.1016","volume":"44","author":[{"given":"O.","family":"Lebreton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Seddiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Abba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Vignes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2023.09.003_bib0150","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s40618-014-0097-2","article-title":"Extrathyroidal manifestations of Graves\u2019 disease: a 2014\u00a0update","volume":"37","author":"Bartalena","year":"2014","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.revmed.2023.09.003_bib0155","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1089\/thy.1999.9.1115","article-title":"Severe thyroid eye disease associated with primary hypothyroidism and thyroid-associated dermopathy","volume":"9","author":"Gleeson","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/j.revmed.2023.09.003_bib0160","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2165\/00128071-200506050-00003","article-title":"Pretibial myxedema: pathophysiology and treatment options","volume":"6","author":"Fatourechi","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.revmed.2023.09.003_bib0165","first-page":"260","article-title":"Localized (pretibial) myxoedema associated with Graves\u2019 disease","volume":"54","author":"Watson","year":"1946","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.revmed.2023.09.003_bib0170","first-page":"6","article-title":"Epidemiological, clinical, therapeutic and evolutive aspects of Basedow-Graves disease in the Department of Internal Medicine at CHU Aristide-Le-Dantec, Dakar (Senegal)","volume":"25","author":"Diagne","year":"2016","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.revmed.2023.09.003_bib0175","first-page":"125","article-title":"Thyroid acropachy: an unusual rheumatic manifestation of Graves\u2019 disease","volume":"23","author":"Capsoni","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2023.09.003_bib0180","doi-asserted-by":"crossref","first-page":"250","DOI":"10.14740\/jem306e","article-title":"Prevalence and clinical characteristics of pretibial myxedema in Chinese outpatients with thyroid diseases","volume":"5","author":"Changgui","year":"2015","journal-title":"J Endocrinol Metab"},{"key":"10.1016\/j.revmed.2023.09.003_bib0185","first-page":"438","article-title":"Dermopathy of Graves\u2019 disease (pretibial myxedema): long-term outcome","volume":"87","author":"Schwartz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2023.09.003_bib0190","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archderm.1986.01660130089033","article-title":"Unusual locations of localized myxedema in Graves\u2019 disease. Report of three cases","volume":"122","author":"Noppakun","year":"1986","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2023.09.003_bib0195","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-4362.1990.tb03758.x","article-title":"Pretibial myxedema localized to scar tissue","volume":"29","author":"Wright","year":"1990","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.revmed.2023.09.003_bib0200","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2165\/00128071-200506050-00003","article-title":"Pretibial myxedema: pathophysiology and treatment options","volume":"6","author":"Fatourechi","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.revmed.2023.09.003_bib0205","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0140-6736(93)92990-B","article-title":"Pretibial myxoedema: a manifestation of lymphoedema?","volume":"341","author":"Bull","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2023.09.003_bib0210","doi-asserted-by":"crossref","first-page":"e49940","DOI":"10.1371\/journal.pone.0049940","article-title":"CD4(+) cells regulate fibrosis and lymphangiogenesis in response to lymphatic fluid stasis","volume":"7","author":"Zampell","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.revmed.2023.09.003_bib0215","first-page":"43","article-title":"The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema","volume":"44","author":"Szuba","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.revmed.2023.09.003_bib0220","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.beem.2011.10.001","article-title":"Thyroid dermopathy and acropachy","volume":"26","author":"Fatourechi","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2023.09.003_bib0225","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0140-6736(53)91210-0","article-title":"Localised pretibial myxoedema treated with cortisone","volume":"265","author":"Inch","year":"1953","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2023.09.003_bib0230","doi-asserted-by":"crossref","first-page":"862","DOI":"10.14740\/jocmr2303w","article-title":"A randomized controlled trial of intralesional glucocorticoid for treating pretibial myxedema","volume":"7","author":"Lan","year":"2015","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.revmed.2023.09.003_bib0235","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jdcr.2018.08.018","article-title":"Pretibial myxedema successfully treated with intralesional hyaluronidase","volume":"4","author":"Hoesly","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.revmed.2023.09.003_bib0240","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jdcr.2020.06.021","article-title":"Pretibial myxedema treated with intralesional hyaluronidase and triamcinolone","volume":"6","author":"Kudlak","year":"2020","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.revmed.2023.09.003_bib0245","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/bmj.304.6820.158","article-title":"Octreotide and Graves\u2019 ophthalmopathy and pretibial myxoedema","volume":"304","author":"Chang","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.revmed.2023.09.003_bib0250","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/thy.1994.4.399","article-title":"Pretibial myxedema and high-dose intravenous immunoglobulin treatment","volume":"4","author":"Antonelli","year":"1994","journal-title":"Thyroid"},{"key":"10.1016\/j.revmed.2023.09.003_bib0255","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.12788\/cutis.0466","article-title":"Treatment of elephantiasic pretibial myxedema with rituximab therapy","volume":"109","author":"Patel","year":"2022","journal-title":"Cutis"},{"key":"10.1016\/j.revmed.2023.09.003_bib0260","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1440-0960.2010.00693.x","article-title":"Treatment-resistant elephantiasic thyroid dermopathy responding to rituximab and plasmapheresis","volume":"53","author":"Heyes","year":"2012","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.revmed.2023.09.003_bib0265","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1556\/OH.2012.29472","article-title":"Treatment of pretibial myxoedema with pentoxifylline","volume":"153","author":"T\u00fcrke","year":"2012","journal-title":"Orv Hetil"},{"key":"10.1016\/j.revmed.2023.09.003_bib0270","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jdcr.2020.09.003","article-title":"Resolution of pretibial myxedema with teprotumumab in a patient with Graves disease","volume":"6","author":"Varma","year":"2020","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.revmed.2023.09.003_bib0275","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jdcr.2021.08.026","article-title":"A case of pretibial myxedema treated with teprotumumab","volume":"16","author":"Petit","year":"2021","journal-title":"JAAD Case Reports"},{"issue":"1","key":"10.1016\/j.revmed.2023.09.003_bib0280","article-title":"Novel teprotumumab treatment of severe thyroid dermopathy; ototoxicity as an adverse side effect","volume":"29","author":"Patel","year":"2023","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.revmed.2023.09.003_bib0285","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13023-020-01652-w","article-title":"Primary lymphedema French National Diagnosis and Care Protocol (PNDS\u00a0; protocole national de diagnostic et de soins)","volume":"16","author":"Vignes","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.revmed.2023.09.003_bib0145","article-title":"Electrosurgical debulking of pretibial myxedema of the foot","volume":"25","author":"Alia","year":"2019","journal-title":"Dermatol Online J"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866323007348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866323007348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:46:46Z","timestamp":1759337206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866323007348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0248866323007348"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2023.09.003","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myx\u0153d\u00e8me pr\u00e9tibial pseudo-tumoral apr\u00e8s une maladie de Basedow\u00a0: un diagnostic diff\u00e9rentiel du lymph\u0153d\u00e8me","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2023.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}